Atopic Dermatitis | Incyte | INCB018424
Pharmaceutical Company/Sponsor:
Incyte
Code:
INCB018424
Title:
A phase 2, randomized, dose-ranging, vehicle-controlled and triamcinolone 0.1% cream– controlled study to evaluate the safety and efficacy of INCB018424 phosphate cream applied topically to adults with atopic dermatitis
Type:
Phase:
Condition/Disease:
Atopic Dermatitis
Intervention(s)/Treatment(s):
Status:
Completed
Link for Additional Information:
